Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    Welcome !
    My account
    Logout

Adamis Pharmaceuticals Corp (ADMP) Stock Forecast 2025 - AI Price Prediction & Analysis

Adamis Pharmaceuticals Corp (ADMP) AI Stock Price Forecast & Investment Analysis

Adamis Pharmaceuticals Corp Stock Price Chart and Technical Analysis

Loading Adamis Pharmaceuticals Corp interactive price chart and technical analysis...

Adamis Pharmaceuticals Corp (ADMP) - Comprehensive Stock Analysis & Investment Research

Deep dive into Adamis Pharmaceuticals Corp's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Adamis Pharmaceuticals Corp, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Adamis Pharmaceuticals Corp: Adamis Pharmaceuticals Corp operates in the Manufacturing sector, making it an emerging small-cap investment.

Adamis Pharmaceuticals Corp (Stock Symbol: ADMP) is a leading company in the Manufacturing sector , specifically operating within the Pharmaceutical Preparation Manufacturing industry.

The organization employs approximately 70600 professionals worldwide and operates under the strategic leadership of CEO Dennis Carlo.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Adamis Pharmaceuticals Corp's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Adamis Pharmaceuticals Corp: With $5M in annual revenue and -502.7% net margin, the company demonstrates developing profitability.

Annual Revenue: $5 million generating a -502.7% net profit margin .

Market Capitalization: $2 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -114.8% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Adamis Pharmaceuticals Corp stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Adamis Pharmaceuticals Corp: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Adamis Pharmaceuticals Corp stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Adamis Pharmaceuticals Corp's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Adamis Pharmaceuticals Corp: Market positioning analysis based on available financial and operational metrics.

Adamis Pharmaceuticals Corp strategically competes in the highly dynamic Pharmaceutical Preparation Manufacturing marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy -23.2% gross margin, indicating strong pricing power and operational efficiency.

Adamis Pharmaceuticals Corp (ADMP) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Adamis Pharmaceuticals Corp stock analysis.

Loading Adamis Pharmaceuticals Corp comprehensive fundamental analysis and insider trading data...

Deep dive into Adamis Pharmaceuticals Corp's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Adamis Pharmaceuticals Corp stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Adamis Pharmaceuticals Corp: With a P/E ratio of -0.54, the market sees the stock as potentially undervalued.

P/E Ratio -0.54x
P/B Ratio -0.16x
Market Cap $2M
EPS $-3.51
Book Value/Share $-4.24
Revenue/Share $1.80
FCF/Share $-0.28
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Adamis Pharmaceuticals Corp converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Adamis Pharmaceuticals Corp: An ROE of -114.8% indicates room for improvement in shareholder value creation.

ROE -114.8%
ROA -73.4%
ROIC -99.5%
Gross Margin -23.2%
Operating Margin -531.7%
Net Margin -502.7%
EBT Margin -293.3%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Adamis Pharmaceuticals Corp's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Adamis Pharmaceuticals Corp: A current ratio of 2.04 indicates strong liquidity.

Current Ratio 2.04x
Quick Ratio 1.65x
D/E Ratio 0.02x
Financial Leverage 1.92x
Interest Coverage -319.1x
Working Capital $-7M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Adamis Pharmaceuticals Corp's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Adamis Pharmaceuticals Corp: Free cash flow of $-41M indicates cash challenges that need attention.

Operating Cash Flow $-40M
Free Cash Flow $-41M
Capital Spending $-1M
FCF/Sales -212.0%
CapEx/Sales 42.9%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Adamis Pharmaceuticals Corp uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Adamis Pharmaceuticals Corp: An asset turnover of 0.04x suggests room for improvement in asset utilization.

Asset Turnover 0.04x
Receivables Turnover 1.5x
Inventory Turnover 5.0x
Fixed Assets Turnover 0.3x
Days Sales Outstanding 251 days
Days Inventory 73 days
Payables Period 251 days
Cash Conversion Cycle 73 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Adamis Pharmaceuticals Corp's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Adamis Pharmaceuticals Corp: With annual revenue of $5M, Adamis Pharmaceuticals Corp represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $5M
Operating Income $-26M
Net Income $-25M
R&D Expense $8M
SG&A Expense $813M
Cost of Goods Sold $6M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 91%
Cash & Short-term Investments 58%
Total Liabilities 48%
Short-term Debt 6%
Accounts Receivable 15%
Inventory 0%
Dividend & Shareholder Information
Shares Outstanding 3M
Growth Metrics (YoY)
EPS Growth -527.4%

Latest Adamis Pharmaceuticals Corp Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Adamis Pharmaceuticals Corp (ADMP) stock price and investment outlook.

, source: Reuters

* ADAMIS PHARMACEUTICALS CORP - AT MEETING, COMPANY OBTAINED CONCURRENCE FROM FDA ON CMC INFORMATION REQUIRED FOR RESUBMISSION OF NDA * ADAMIS PHARMACEUTICALS CORP - BELIEVES IT CAN GENERATE ...

, source: equities

An H.C. Wainwright & Co. report explains the deal, which concerns a new single-dose epinephrine injection for severe allergic reactions. In a July 2 research note, analyst Jason Kolbert with H.C.

, source: Reuters

Two sprawling digital black markets operating on the communications platform Telegram have been removed, the service said on Thursday. Autos & Transportationcategory Deere beats second-quarter ...

Adamis Pharmaceuticals Corp Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of Adamis Pharmaceuticals Corp against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Adamis Pharmaceuticals Corp Stock Forecast

How accurate are Adamis Pharmaceuticals Corp stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for ADMP predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Adamis Pharmaceuticals Corp stock price forecasts?

Our analysis considers Adamis Pharmaceuticals Corp's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Adamis Pharmaceuticals Corp a good investment in 2025?

Based on our AI analysis, Adamis Pharmaceuticals Corp shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Adamis Pharmaceuticals Corp forecasts updated?

Adamis Pharmaceuticals Corp stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Adamis Pharmaceuticals Corp Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Adamis Pharmaceuticals Corp stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...